- ACEL Stock Page
Alfacell Corporation (NASDAQCM:ACEL)
Last Update: Sep 05 at 3:55 ET
| Change: | 0.01 (1.92%) |
| Last Trade: | 0.53 |
| Prev Close: | 0.52 |
| Share Volume: | 29,100 |
| Market Cap: | 24.58M |
| EPS (Earnings per share): | -0.26 |
| P/E (Price/earning ratio): | N/A |
| P/B (Price/book ratio): | N/A |
| Stock Price History | |
|---|---|
| Beta: | 0.19 |
| 52 week change: | -78.30% |
| 52 week high: | 2.69 |
| 52 week low: | 0.35 |
| 10 day moving avarage: | 0.51 |
| 200 day moving avarage: | 1.52 |
| Dividends | |
| Ex dividend date: | N/A |
| Dividend yield: | N/A |
| Dividend rate: | N/A |
| Share Statistics | |
| Avarage 10 day volume: | 40,800 |
| Shares outstanding: | 47,276,880 |
| Short interest date: | Aug 12, 2008 |
| Short shares: | 1,866,433 |
| Short ratio: | 15.50 |
| Short % of float: | 4.30% |
Fri, 5 Sep 2008 3:55 PM
After-Hours:
0.40
-0.13 (-24.53%)
| Today | 5d | 1m | 3m | 6m | 1y | 5y |
Latest News for ACEL
-
EDGAR Online
- Aug 01 at 4:04 ET
ALFACELL CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tra
Company Profile
Sector: Healthcare
Industry: Drugs
A biopharmaceutical company
A biopharmaceutical company engaged in the discovery and development of a new class of therapeutic drugs for the treatment of cancer and other pathological conditions.
ACEL News
-
EDGAR Online
- Aug 01 at 4:04 ET
ALFACELL CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tra -
PR Newswire
- Aug 01 at 3:30 ET
Alfacell Receives NASDAQ Delisting Letter -
PR Newswire
- Jul 21 at 7:30 ET
Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacell's ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines -
EDGAR Online
- Jul 18 at 3:41 ET
ALFACELL CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tra -
PR Newswire
- Jul 18 at 3:30 ET
Alfacell Receives NASDAQ Non-Compliance Notification -
PR Newswire
- Jul 15 at 7:30 ET
Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel -
EDGAR Online
- Jun 26 at 4:10 ET
ALFACELL CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tra -
PR Newswire
- Jun 26 at 3:36 ET
Alfacell Receives NASDAQ Non-Compliance Notification -
EDGAR Online Financials
- Jun 14 at 8:04 ET
ALFACELL CORP Financials -
StarMine
- Jun 10 at 8:45 ET
New Star Analyst Rankings for ALFACELL CORP
Top members owning ACEL
-
Top 39%
-3.68%3m:
-3.68%YTD: